Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Levetiracetam for neuropathic pain in adults.
Safety of TNF inhibitors in adolescents and children.
Anesthesia for the obstetric patient with multiple sclerosis.
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
DNase hypersensitive sites and association with multiple sclerosis.
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
Immune surveillance and response to JC virus infection and PML.
[Clinical characteristics of multiple sclerosis in the Tomsk region.]
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Treatment of relapsing-remitting multiple sclerosis: current and future algorithms.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
NMDA receptor antibodies associated with distinct white matter syndromes.
Diazepam Inhibits Proliferation of Lymph Node Cells Isolated from Rats with Experimental Autoimmune Encephalomyelitis.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: preliminary clinical experience.
Neurofascin antibodies in inflammatory neuropathy: How many needles make a haystack?
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Pages